Tata 1mg, one of India’s leading e-pharmacy platforms, has entered into a strategic alliance with ClickPost, a logistics intelligence company, to enhance and automate its medicine delivery network through AI-powered Performance-Based Courier
Novo Nordisk India partners with Emcure Pharma to launch Poviztra, expanding access to semaglutide 2.4 mg for safe, effective weight loss across India.
.png)
Pfizer has clinched a major victory in the race for next-generation obesity treatments, signing a deal to acquire development-stage drugmaker Metsera Inc. after outbidding rival Novo Nordisk, the maker of Ozempic and Wegovy...
.png)
Eli Lilly’s anti-obesity drug Mounjaro has become India’s highest-selling pharmaceutical by value in October, with sales touching ?100 crore ($11.38 million). The surge reflects the growing demand for anti-obesity medications in a country...
The latest portable ultrasound device, Sonosite MT, by FUJIFILM Sonosite, is the addition to the point-of-care product range, PX, LX, and the ST. The stand provides clinicians with flexibility as the clamshell-like MT can be utilized with or...
Venus Remedies, one of the world’s top 10 manufacturers of fixed-dosage injectable drugs, has received new marketing authorizations in Vietnam for three key products methotrexate, cefuroxime, and irinotecan. These latest approvals strengthen the
Medicity, one of India’s premier super-speciality hospitals and Best Private Hospital in India, and it has unveiled its Advanced Surgical Heart Failure Clinic a state-of-the-art centre focused on the diagnosis, surgical treatment
Morgan Stanley PE-backed Omega Hospitals, based in Hyderabad, has successfully acquired Cytecare Hospitals, a prominent cancer care facility located in Bengaluru. This strategic acquisition signifies Omega's entry into a rapidly expanding
Pharmaceutical giant Sun Pharmaceutical Industries is anticipated to report consistent revenue growth, albeit with subdued profitability in its results for the September 2025 quarter (Q2FY26), impacted by increased costs associated with its US
Continuing its growth journey after the major investment in Hyderabad, Eli Lilly and Company now plans to build a USD 3 billion manufacturing facility in Katwijk, the Netherlands, within the Leiden Bio Science Park. The new site will increase...
, CDSCO.jpg)